Top Purchase Related
Home
>
Node
>
Subnode

Enzyme inhibitor therapy of hypertension

Prosnitz, E.H.

Arizona Medicine 36(4): 286-288

1979

ISSN/ISBN: 0004-1556
PMID: 220936
Document Number: 150292

Document emailed within 1 workday
Secure & encrypted payments

Katel'nitskaia, L.I.; Ivanchenko, D.N.; Khansheva, L.A.; Kholoshina, L.V.; Glova, S.E.; Pleskachev, S.A. 2006: Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril Kardiologiia 46(3): 35-38
Pavliukova, E.N.; Bakhmet'eva, T.A.; Puzyrev, K.V.; Karpov, R.S. 2006: Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril Kardiologiia 46(9): 19-25
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Ryan, E.; Muldowney, F.P. 1983: Use of angiotensin i to Ii converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension Irish Medical Journal 76(4): 175; 177-178
Rosolová, H.; Cech, F.; Sefrna, F. 2002: Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study Vnitrni Lekarstvi 48(8): 701-706
Karpov, I.A.; Deev, A.D. 2003: Russian study of efficacy and safety of an angiotensin converting enzyme inhibitor quinapril in patients with hypertension Kardiologiia 43(6): 28-32
Cadilhac, M.; Giudicelli, J.F. 1986: Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in spontaneously hypertensive rats Archives Internationales de Pharmacodynamie et de Therapie 284(1): 114-126
Vladkovs'kyĭ, I.K.; Plesh, I.A.; Haĭdukov, V.A.; Loboda, M.I. 1996: The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-Ii hypertension Likars'ka Sprava 1996(3-4): 113-117
Britov, A.N.; Alamdarova, I.I.; Deev, A.D.; Orlov, A.A. 2003: Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension Kardiologiia 43(10): 66-71
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Sigusch, H.H.; Surber, R.; Vogt, S.; Müller, S.; Hoffmann, A. 1997: Absence of association between angiotensin I-converting enzyme (ACE) DD genotype and the frequency of ACE inhibitor therapy Die Pharmazie 52(7): 565-566
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Israili, Z.H.; Hall, W.D. 1992: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology Annals of Internal Medicine 117(3): 234-242
Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Bakaev, R.G.; Strutynskiĭ, A.V.; Kallaeva, A.N.; Glazunov, A.B.; Voronina, M.A.; Pekhtereva, D.A.; Moshkova, N.K.; Chudnovskaia, E.A.; Kochetkov, B.M. 2011: Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction Klinicheskaia Meditsina 89(1): 23-26
Malacco, E.; Landi, C.; Magenta, M.; Sartini, C. 1986: Hypertension therapy in the elderly. Our experience with converting enzyme inhibitors Minerva Medica 77(47-48): 2217-2220
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Franca, G.; Cosenzi, A.; Piemontesi, A.; Bellini, G. 1988: Efficacy of angiotensin-converting enzyme inhibitors in the therapy of arterial hypertension in the aged Giornale di Clinica Medica 69(11): 665-669
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056